Cita APA (7a ed.)
Eigentler, T., Thomas, I., Samoylenko, I., Erdmann, M., Heinzerling, L., Ochsenreither, S., . . . Gnad-Vogt, U. (Feb 2025). Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma. Journal for Immunotherapy of Cancer. https://doi.org/10.1136/jitc-2024-009352
Cita Chicago Style (17a ed.)
Eigentler, Thomas, et al. "Phase I Study of Intratumoral Administration of CV8102 in Patients with Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma." Journal for Immunotherapy of Cancer Feb 2025. https://doi.org/10.1136/jitc-2024-009352.
Cita MLA (9a ed.)
Eigentler, Thomas, et al. "Phase I Study of Intratumoral Administration of CV8102 in Patients with Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma." Journal for Immunotherapy of Cancer, Feb 2025, https://doi.org/10.1136/jitc-2024-009352.
Precaución: Estas citas no son 100% exactas.